Crowdonomics
WatchlistPortfolio
FRAMEWORK

Reg CF · Revenue Share · Jul 2024

ClosedReached targetReg CFRevenue Share
via WeFunderView campaign
Raised
$98.5K / $124K max
79% of ceiling · target hit day 4
Investors
34
$2.9K avg
Valuation
—
—

Raised over time

Cumulative raisedInvestors
$99K$49K$0
34170
Jul 14, 2024 · openedAug 7, 2024 · last reading
Target ($50K) hit — Jul 18, 2024, day 4Deadline Apr 30, 2025 — 266 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
FY2022
$0
−$36K
FY2023
RevenueNet income
Metric
FY2022 unaudited
FY2023 unaudited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$19,870
Net income
$0
-$36,474
Taxes paid
$0
$0
Balance sheet
Cash
$0
$131,783
Accounts receivable
$0
$0
Total assets
$0
$496,054
Short-term debt
$0
$43,043
Long-term debt
$0
$0
Total liabilities
$0
$43,043
Other
Headcount
—
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Revenue share2%
Payout multiple1.5×

Perks

Pay investors 2% of revenues each quarter until 100% of your principal is returned plus 50% on top

Offering details

Target$50,000
Max$124,000
Min investment$1,000
OpenedJul 14, 2024
DeadlineApr 30, 2025
ClosedAug 7, 2024
Days active24

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-24-000765

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.